journal article·2015-02-17Open access

Ocular Tissue Engineering: Current and Future Directions

D. Karamichos

Abstract

Tissue engineering (TE) is a concept that was first emerged in the early 1990s to provide solutions to severe injured tissues and/or organs [1]. The dream was to be able to restore and replace the damaged tissue with an engineered version which would ultimately help overcome problems such as donor shortages, graft rejections, and inflammatory responses following transplantation. While an incredible amount of progress has been made, suggesting that TE concept is viable, we are still not able to overcome major obstacles. In TE, there are two main strategies that researchers have adopted: (1) cell-based, where cells are been manipulated to create their own environment before transplanted to the host, and (2) scaffold-based, where an extracellular matrix is created to mimic in vivo structures. TE approaches for ocular tissues are available and have indeed come a long way, over the last decades; however more clinically relevant ocular tissue substitutes are needed. Figure 1 highlights the importance of TE in ocular applications and indicates the avenues available based on each tissue.[...].
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Corneal Surgery and Treatments · Ocular Disorders and Treatments · Ocular Surface and Contact Lens

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

Department of Ophthalmology, Dean McGee Eye Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA

Funding

NEI

References (16)

Show source-provided references
1. Ocular tissue engineering10.1007/978-0-387-34133-0_27 ↗
2. Long-term restoration of damaged corneal surfaces with autologous cultivated corneal epithelium10.1016/S0140-6736(96)11188-0 ↗
3. Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells10.1056/NEJM200007133430202 ↗
4. Corneal melt after amniotic membrane transplant10.1097/01.ico.0000127480.16090.89 ↗
5. Development of cultivated mucosal epithelial sheet transplantation for ocular surface reconstruction10.1111/j.1525-1594.2004.07319.x ↗
6. Transplantable cultivated mucosal epithelial sheet for ocular surface reconstruction10.1016/j.exer.2003.09.004 ↗
7. Lens biology: Development and human cataractogenesis10.1016/S0168-9525(99)01738-2 ↗
8. Posterior capsule opacification10.1016/0039-6257(92)90073-3 ↗
9. A unique aged human retinal pigmented epithelial cell line useful for studying lens differentiation in vitro
10. Transplantation of RPE in age-related macular degeneration: Observations in disciform lesions and dry RPE atrophy10.1007/BF00941722 ↗
11. Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD10.1177/112067219900900310 ↗
12. Outcome of transplantation of autologous retinal pigment epithelium in age-related macular degeneration: A prospective trial10.1167/iovs.04-0118 ↗
13. Transplantation of autologous retinal pigment epithelium in eyes with foveal neovascularization resulting from age-related macular degeneration: A pilot study10.1016/S0002-9394(01)01373-3 ↗
14. Advances in retinal tissue engineering10.3390/ma5010108 ↗
15. Biomaterials in drug delivery and tissue engineering: One laboratory’s experience10.1021/ar9800993 ↗
16. Optimisation of polymer scaffolds for retinal pigment epithelium (RPE) cell transplantation10.1136/bjo.2009.166728 ↗